ID

DB10553||

名称

Peanut

描述

Peanut allergenic extract is used in allergenic testing.

cas号

唯一标识码

QE1QX6B99R

状态

组

approved,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

消除途径

种类

Cell-mediated Immunity

Increased Histamine Release

Non-Standardized Food Allergenic Extract

盐类

蛋白质结合

清除

同义词

国际品牌

配送量

产品

name:Food - Plant Source, Peanut Arachis hypogaea
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-3456
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Percutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Food - Plant Source, Peanut Arachis hypogaea
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-3455
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 1)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-101
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:3 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 10)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-110
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 10)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-110
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 11)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-111
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:300 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 2)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-102
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:6 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 3)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-103
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 3)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-103
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 4)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-104
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:20 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 5)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-105
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:40 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 6)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-106
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:80 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 7)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-107
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 7)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-107
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 8)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-108
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 8)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-108
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA (Level 9)
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-109
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:200 mg/1
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA Initial Dose Escalation
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-113
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:PALFORZIA Initial Dose Escalation
labeller:Aimmune Therapeutics
ndc-id:
ndc-product-code:71881-113
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-01-31
ended-marketing-on:
dosage-form:Powder
strength:
route:Oral
fda-application-number:BLA125696
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-1550
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-1553
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0379
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-6193
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.10 g/1mL
route:Percutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-1551
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-1552
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-5786
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Peanut Food
labeller:Allergy Laboratories, Inc.
ndc-id:
ndc-product-code:54575-433
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:1 g/20mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC

混合物

name:Peanut
ingredients:Peanut
name:Peanut
ingredients:Peanut
name:Peanut
ingredients:Peanut
name:Peanut
ingredients:Peanut
name:Peanut
ingredients:Peanut
name:Peanut Food
ingredients:Peanut
name:Peanut
ingredients:Peanut
name:Food - Plant Source, Peanut Arachis hypogaea
ingredients:Peanut
name:Food - Plant Source, Peanut Arachis hypogaea
ingredients:Peanut
name:PALFORZIA Initial Dose Escalation
ingredients:Peanut + Peanut
name:PALFORZIA Initial Dose Escalation
ingredients:Peanut + Peanut
name:PALFORZIA (Level 1)
ingredients:Peanut
name:PALFORZIA (Level 2)
ingredients:Peanut
name:PALFORZIA (Level 3)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 3)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 4)
ingredients:Peanut
name:PALFORZIA (Level 5)
ingredients:Peanut
name:PALFORZIA (Level 6)
ingredients:Peanut
name:PALFORZIA (Level 7)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 7)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 8)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 8)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 9)
ingredients:Peanut
name:PALFORZIA (Level 10)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 10)
ingredients:Peanut + Peanut
name:PALFORZIA (Level 11)
ingredients:Peanut
name:Peanut
ingredients:Peanut

包装者

生产者

价格

受影响的生物体

剂量

form:Injection, solution
route:Percutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Percutaneous; Subcutaneous
strength:0.1 g/1mL
form:Powder
route:Oral
strength:3 mg/1
form:Powder
route:Oral
strength:300 mg/1
form:Powder
route:Oral
strength:6 mg/1
form:Powder
route:Oral
strength:20 mg/1
form:Powder
route:Oral
strength:40 mg/1
form:Powder
route:Oral
strength:80 mg/1
form:Powder
route:Oral
strength:200 mg/1
form:Powder
route:Oral
strength:
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.05 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Percutaneous
strength:0.10 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.05 g/1mL
form:Injection, solution
route:Percutaneous; Subcutaneous
strength:1 g/20mL

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

序列

实验性质

外部标识符

resource：PubChem Substance
identifier：347910713
resource：Wikipedia
identifier：Peanut
resource：RxCUI
identifier：891658

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应